Cohen L H, Kaplan M, Bernhard V M
Arch Surg. 1986 Jun;121(6):708-15. doi: 10.1001/archsurg.1986.01400060104015.
Streptokinase was injected directly into the arterial tree following balloon-catheter embolectomy on 13 occasions to remove residual thrombus that could not be mechanically retrieved in 12 patients with imminent limb (ten patients) or kidney (two patients) necrosis. Effective lysis, confirmed by arteriography, pulse return, and increased ankle pressures, was achieved in 11 trials (85%). Bleeding complications, minor in three patients and severe in two patients, were ascribed to systemic lysis although other factors were contributory. One of five deaths was related to therapy. Six limbs were salvaged. The average total dose of streptokinase used, 110,000 units, was given in intermittent boluses of 25,000 to 50,000 units injected below a clamp placed to temporarily occlude distal circulation. Safe application of this technique requires intraoperative monitoring of coagulation parameters, aggressive replacement therapy, and prudent patient selection. This preliminary experience suggests that intraoperative lytic therapy (1) is an effective method for clearing thrombus not amenable to mechanical extraction and (2) may improve patency and tissue salvage.
在13例患者中,于球囊导管取栓术后将链激酶直接注入动脉系统,以清除12例即将发生肢体(10例)或肾脏(2例)坏死患者中无法通过机械方法取出的残余血栓。通过动脉造影、脉搏恢复和踝部压力升高证实有效的溶栓在11次试验中实现(85%)。出血并发症,3例轻微,2例严重,尽管有其他因素起作用,但归因于全身溶栓。5例死亡中有1例与治疗有关。6条肢体得以挽救。链激酶的平均总用量为110,000单位,以25,000至50,000单位的间歇推注方式给药,注射于用于暂时阻断远端循环的夹子下方。安全应用该技术需要术中监测凝血参数、积极的替代治疗以及谨慎的患者选择。这一初步经验表明,术中溶栓治疗(1)是清除无法通过机械方法取出的血栓的有效方法,(2)可能改善血管通畅性并挽救组织。